Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target

被引：0
|
作者：
Bu, Rong [1 ]
Bavi, Prashant [1 ]
Hussain, Azhar R. [1 ]
Jehan, Zeenath [1 ]
Abubaker, Jehad [1 ]
Al-Sanea, Nasser A. [1 ]
Abduljabbar, Alaa S. [1 ]
Ashari, Luai H. [1 ]
Al-Homoud, Samar J. [1 ]
Al-Dayel, Fouad [1 ]
George, Thara [1 ]
Qadri, Zeeshan [1 ]
Hassan, Nurul [1 ]
Prabhakaran, Sarita E. [1 ]
Ahmed, Magbool [1 ]
Uddin, Shahab [1 ]
Al-Kuraya, Khawla S. [1 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-2980
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2980
引用
收藏
页数：1
相关论文
共 50 条
  • [21] UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
    Guo, Yanjing
    Chen, Xinyu
    Zhang, Xiaowei
    Hu, Xichun
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma
    Li, Linwei
    Li, Xiaoyan
    Wang, Wenyu
    Gao, Tianhui
    Shi, Zuxuan
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 201 - 206
  • [23] Nobiletin inhibits cell proliferation and invasion via suppression of UBE2C in hepatocellular carcinoma
    Su, Jinzhan
    Fan, Shufeng
    Su, Dongying
    Li, Miaoer
    Song, Xia
    SCIENCEASIA, 2024, 50 (05):
  • [24] Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma
    Li, Xiao
    Ma, Zhaosheng
    Mei, Linhang
    AGING-US, 2023, 15 (15): : 7397 - 7407
  • [25] The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma
    Zhan, Ping
    Lu, Yuyan
    Lu, Jing
    Cheng, Yizhe
    Luo, Changhong
    Yang, Fan
    Xi, Wenqing
    Wang, Jinzhu
    Cen, Xuesong
    Wang, Fuqiang
    Xie, Chengrong
    Yin, Zhenyu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival
    Nousiainen, Ruth
    Eloranta, Katja
    Isoaho, Noora
    Cairo, Stefano
    Wilson, David B.
    Heikinheimo, Markku
    Pihlajoki, Marjut
    FRONTIERS IN GENETICS, 2023, 14
  • [27] Fabrication of an immunosensor for quantitative detection of breast cancer biomarker UBE2C
    Jayanthi, V. S. P. K. Sankara Aditya
    Das, Asim Bikas
    Saxena, Urmila
    RSC ADVANCES, 2019, 9 (29) : 16738 - 16745
  • [28] UBE2C is a diagnosis and therapeutic biomarker involved in immune infiltration of cancers including lung adenocarcinoma
    Cai, Daxia
    Tian, Feng
    Wu, Minhua
    Tu, Jianfei
    Wang, Yonghui
    JOURNAL OF CANCER, 2024, 15 (06): : 1701 - 1717
  • [29] Overexpression of UBE2C correlates with poor prognosis in gastric cancer patients
    Zhang, H. -Q.
    Zhao, G.
    Ke, B.
    Ma, G.
    Liu, G. -L.
    Liang, H.
    Liu, L. -R.
    Hao, X. -S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1665 - 1671
  • [30] High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression
    Shen, Zhihua
    Jiang, Xiaofan
    Zeng, Chao
    Zheng, Shaojiang
    Luo, Botao
    Zeng, Yumei
    Ding, Ranran
    Jiang, Hanguo
    He, Qiyi
    Guo, Junli
    Jie, Wei
    BMC CANCER, 2013, 13
12345